Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
MERCK FROSST CANADA LTD	16711 TRANS-CANADA HWY KIRKLAND QUEBEC H9H 3L1

International Classification(s)

• A01N:PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLA....

• 2003 Application Filing Year
• A01N Class
• 1357 Applications Filed
• 628 Patents Issued To-Date
• 46.28 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Aspiotis, Renee	Montreal, CA	12	48
# of filed Patents : 12 Total Citations : 48
Dube, Daniel	St. Lazare, CA	40	291
# of filed Patents : 40 Total Citations : 291
Dube, Laurence	Pierrefonds, CA	10	40
# of filed Patents : 10 Total Citations : 40
Gallant, Michel	Montreal, CA	39	311
# of filed Patents : 39 Total Citations : 311
Girard, Yves	Ile-Bizard, CA	49	438
# of filed Patents : 49 Total Citations : 438
Lacombe, Patrick	Montreal, CA	26	149
# of filed Patents : 26 Total Citations : 149
Macdonald, Dwight	L'lle Bizard, CA	33	167
# of filed Patents : 33 Total Citations : 167

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A01N Class

• 0 % this patent is cited more than
• 17 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
March 11, 2008	US,7342024,B2   US7342024B2	GRANTED PATENT AS SECOND PUBLICATION
March 16, 2006	US,20060058316,A1   US20060058316A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 7342024

4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

---

Abstract

---

Compounds represented by Formula (I): or a pharmaceutically acceptable salt thereof, are phosphodiesterase 4 inhibitors useful in the treatment of asthma and inflammation and useful for the enhancement of cognition ##STR00001##

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• STCH2016
• FP2016
• LAPS2016
• REMI2015
• FPAY2011
• I2008
• AS2006
• P2006
• F2003
• AS2003
• PD2002

Date	Code	Event	Description
Apr 11, 2016	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Mar 11, 2016	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Mar 11, 2016
Mar 11, 2016	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES
Oct 23, 2015	REMI	MAINTENANCE FEE REMINDER MAILED
Aug 24, 2011	FPAY	FEE PAYMENT	year of fee payment: 4
Mar 11, 2008	I	Issuance
Jul 06, 2006	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MERCK FROSST CANADA AND COMPANY;REEL/FRAME:017996/0135 Owner name: MERCK FROSST CANADA LTD., CANADA Effective Date: Jul 06, 2006
Mar 16, 2006	P	Published
Nov 19, 2003	F	Filing
Oct 17, 2003	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DUBE, DANIEL;ASPIOTIS, RENEE;GALLANT, MICHEL;AND OTHERS;REEL/FRAME:017312/0048 Owner name: MERCK FROSST CANADA & CO., CANADA Effective Date: Oct 17, 2003
Nov 22, 2002	PD	Priority Date